2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Emesis: new trials by email Literature Review of Emesis trials Research Report on Emesis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis aprepitant + dexamethasone, metoclopramide + dexamethasone - Emesis | Phase 3 | Terminated | S. Maria Hospital, Terni | 303 | 2009-09-01 | 2014-01-06 |
| Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients Aprepitant, dexamethasone - Emesis | Phase 3 | Terminated | S. Maria Hospital, Terni | 580 | 2009-09-01 | 2013-01-23 |
Vomiting (2) · Breast Neoplasms (1)
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Aprepitant (2) · Dexamethasone (2) · Metoclopramide (1)
Italy (2)
Fausto Roila, MD (2)
PMID 16314401, PMID 10824073, PMID 11497388, PMID 12712486, PMID 12784346, PMID 14504060, PMID 14559886, PMID 14635083, PMID 14966097, PMID 15837996, PMID 16766588, PMID 24323030, PMID 25743855, PMID 8996133
2008 (2)